JCO Precision Oncology

Published by: American Society of Clinical Oncology  

People

  1. Ladanyi
    Ladanyi
  2. Berger
    Berger
  3. Solit
    Solit
  4. Arcila
    Arcila
  5. Drilon
    Drilon
  6. Riely
    Riely
  7. Schultz
    Schultz
  8. Mandelker
    Mandelker
  9. Stadler
    Stadler
  10. Carlo
    Carlo

Groups

  1. GSK Faculty (56)
  2. Human Oncology and Pathogenesis Program (56)
  3. Department of Medicine (49)
  4. Solid Tumor Oncology Division (49)
  5. Department of Pathology and Laboratory Medicine (48)
  6. Tow Center for Developmental Oncology (TCDO) (35)
  7. Weinberg Fellows (31)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (30)
  9. Sloan Kettering Institute Postdocs (27)
  10. Epidemiology and Biostatistics (25)
Search Within
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (55)
  2. Review (1)
Groups
  1. GSK Faculty (56)
  2. Human Oncology and Pathogenesis Program (56)
  3. Department of Medicine (49)
  4. Solid Tumor Oncology Division (49)
  5. Department of Pathology and Laboratory Medicine (48)
  6. Tow Center for Developmental Oncology (TCDO) (35)

More Groups

People
  1. Marc Ladanyi (24)
  2. Michael Berger (20)
  3. David Solit (16)
  4. Ahmet Zehir (14)
  5. Zsofia Stadler (10)
  6. Alexander Drilon (9)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (6)
  4. 2022 (10)
  5. 2021 (3)
  6. 2020 (8)

More Years

Publishers
  1. American Society of Clinical Oncology (56)

Results (56)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of clonal hematopoiesis on solid tumor progression following radiation therapy
    Journal Article

    Tao, J. J.; Setton, J.; Vela, P. S.; Safonov, A. M.; Comen, E. A.; Braunstein, L. Z.; Reis-Filho, J. S.; Riaz, N.; Powell, S. N.; Levine, R. L.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Clinical activity of mitogen-activated protein kinase inhibitors in patients with MAP2K1 (MEK1)-mutated metastatic cancers
    Review

    Dankner, M.; Rousselle, E.; Petrecca, S.; Fabi, F.; Nowakowski, A.; Lazaratos, A. M.; Vincent Rajadurai, C.; Stein, A. J. B.; Bian, D.; Tai, P.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Optimizing mainstreaming of genetic testing in parallel with ovarian and endometrial cancer tumor testing: How do we maximize our impact?
    Journal Article

    Liu, Y. L.; Sia, T. Y.; Varice, N.; Wu, M.; Byrne, M.; Khurram, A.; Kemel, Y.; Sheehan, M.; Galle, J.; Sabbatini, P.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Response to crizotinib after entrectinib resistance in ROS1-rearranged, MET-amplified lung adenocarcinoma
    Journal Article

    Vaz, V. R.; Gandhi, M. M.; Ricciuti, B.; Alessi, J. V.; Elkrief, A.; Ladanyi, M.; Vanderbilt, C.; Pecci, F.; Aldea, M.; Barrichello, A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Concordance in oncogenic alterations between the primary tumor and advanced disease: Insights into the heterogeneity of intrahepatic cholangiocarcinoma
    Journal Article

    McIntyre, S. M.; Preston, W. A.; Walch, H.; Sharib, J.; Kundra, R.; Sigel, C.; Lidsky, M. E.; Allen, P. J.; Morse, M. A.; Chen, W.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Combination of MDM2 and targeted kinase inhibitors results in prolonged tumor control in lung adenocarcinomas with oncogenic tyrosine kinase drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Smith, R. S.; Vojnic, M.; Hayashi, T.; Khodos, I.; Markov, V.; Liu, Z.; Lui, A. J. W.; Bloom, J. L.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Consideration of a novel surgical approach in the management of gastric adenocarcinoma and proximal polyposis syndrome
    Journal Article

    Judge, S. J.; Gearty, S. V.; Catchings, A.; Ranganathan, M.; Roehrl, M. H.; Vardhana, S. A.; Tang, L.; Stadler, Z. K.; Strong, V. E.
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Serial cell-free DNA sequencing in ROS1 fusion-positive lung cancers during treatment with entrectinib
    Journal Article

    Choudhury, N. J.; Woo, H. J.; Chen, M.; Shah, R.; Donoghue, M.; Berger, M.; Drilon, A.
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • NF1-driven rhabdomyosarcoma phenotypes: A comparative clinical and molecular study of NF1-mutant rhabdomyosarcoma and NF1-associated malignant triton tumor
    Journal Article

    de Traux de Wardin, H.; Dermawan, J. K.; Vanoli, F.; Jiang, S. C.; Singer, S.; Chi, P.; Tap, W.; Wexler, L. H.; Antonescu, C. R.
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save

    • JCO Precision Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 Unknown
    Jco Precision Oncology Lippincott Williams & Wilkins
    Jco Precision Oncology American Society of Clinical Oncology
    Jco Precision Oncology American Society of Clinical Oncology
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    Unknown (24734284) 24734284 American Society of Clinical Oncology